PROFORMA stands for Pharmacovigilance infrastructure and post-marketing surveillance system capacity building.

The project started in March 1, 2018 and ended with a final closure symposium held on December 19, 2024 in Stockholm.

PROFORMA was a consortium between academia and regulatory authorities from four (4) African countries; Ethiopia, Kenya, Tanzania, and Rwanda and other international collaborators including Karolinska Institutet (Sweden) and WHO collaborating Centre’s in Pharmacovigilance Centre-Lareb, Netherland. The initiative aimed to bolster pharmacovigilance in Ethiopia, Kenya, Rwanda, and Tanzania by building sustainable capacity for post-marketing surveillance of medicines, particularly in scenarios like mass drug administration and clinical trials.